Not currently recruiting at UCSD
Long-term Safety of Tafamidis in Subjects With Transthyretin Cardiomyopathy
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at La Jolla, California and other locations
- Dates
- study startedestimated completion
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Pfizer
- Links
- To obtain contact information for a study center near you, click here.
- ID
- NCT02791230
- Phase
- Phase 3
- Study Type
- Interventional
- Last Updated